Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV-1 Candidate Vaccine Delivered by a Replication-Defective Recombinant Adenovirus Vector

BACKGROUND: The development of an effective human immunodeficiency virus (HIV) vaccine is a high global priority. Here, we report the safety, tolerability, and immunogenicity of a replication-defective recombinant adenovirus serotype 5 (rAd5) vector HIV-1 candidate vaccine. METHODS: The vaccine is a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Catanzaro, Andrew T., Koup, Richard A., Roederer, Mario, Bailer, Robert T., Enama, Mary E., Moodie, Zoe, Gu, Lin, Martin, Julie E., Novik, Laura, Chakrabarti, Bimal K., Butman, Bryan T., Gall, Jason G. D., King, C. Richter, Andrews, Charla A., Sheets, Rbecca, Gomez, Phillip L., Mascola, John R., Nabel, Gary J., Graham, Barney S.
Format: Artigo
Idioma:Inglês
Publicat: 2006
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2428071/
https://ncbi.nlm.nih.gov/pubmed/17109335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/509258
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars